Remove journals pharmaceutical-technology pharmaceutical-technology-march-2024
article thumbnail

NHC Comments on NIST Draft March-In Framework

Putting Patients First Blog

This balance is critical to ensure that march-in rights are strategically employed to tackle substantial public health issues, such as unmet medical needs or access barriers, without impeding the innovation imperative for medical advancement.